Navigation Links
Quintessence cancer treatment chosen for clinical studies

Madison, Wis. - Quintessence Biosciences, a biopharmaceutical company developing cancer therapies, has announced that QB139, one of its EVade cancer treatments, has been selected for preclinical testing and human clinical trials.

Quintessence said that pending a favorable preclinical safety assessment, it would submit to the

Source:wistechnology.com By WTN News 11/09/06


Page: 1

Related biology technology :

1. Quintessence Biosciences advances cancer drug
2. Quintessence Biosciences names new president
3. Quintessence division to develop drug tests with NIH grant
4. Quintessence Biosciences forms cancer therapeutic advisory board
5. Quintessence Secures Financing
6. NeoClone gets $750K for ovarian cancer detection
7. Medical College receives $1.4M cancer grant
8. GE Healthcare partners with UNC on breast cancer imaging research
9. Lance Armstrong and the future of cancer care
10. Medical College part of $5M cancer study
11. UW finds new path to anti-cancer agents
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2017)... ... , ... National executive search firm, Slone Partners, announces the ... biomarker expertise, as VP of Scientific Affairs at Cambridge Biomedical. , Established ... and sample testing services. The organization acts as a leading provider of customized ...
(Date:6/19/2017)... ... June 19, 2017 , ... EDETEK, Inc., a clinical ... it is launching two new additions of its award-winning cloud-based platform CONFORM™: Information ... the DIA 2017 Annual Meeting in Chicago, IL, June 19-22, 2017. , “Modern ...
(Date:6/16/2017)... ... June 16, 2017 , ... ... solutions, today announced that its Anzo Smart Data Lake® (Anzo SDL) solution ... category for the 2017 Software & Information Industry Association (SIIA) CODiE Awards. ...
(Date:6/15/2017)... PA (PRWEB) , ... June 15, 2017 , ... ... Esther Klein Gallery (EKG) follows an artist’s journey through creative experimentation and interdisciplinary ... 2017 and runs through July 22nd. An opening reception will be held at ...
Breaking Biology Technology:
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
(Date:4/13/2017)... India , April 13, 2017 According to ... Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, ... MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 Billion ... Growth Rate (CAGR) of 17.3%. ... MarketsandMarkets ...
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
Breaking Biology News(10 mins):